ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The Food and Drug Administration approved a new, highly effective HIV-prevention medication. The drug nearly eliminated HIV’s spread among people given an injection twice a year in clinical ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

The Food and Drug Administration has approved the world's only twice-a-year shot to prevent HIV.

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells’ transportation systems for its own survival.

While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing.

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to ...

Learn how Medicaid and SNAP provided life-saving support after an HIV diagnosis, enabling the author to rebuild their life as a nurse in California.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

LOUISVILLE, Ky. (WAVE) - A woman is suing the Louisville Metro Department of Corrections and Louisville Metro Government on claims she was denied her HIV medication while she was detained which caused ...

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks ...